Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

JANSSEN - CILAG FARMACÊUTICA LDA

NIF 500189412
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €24,814,006 151 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €24,814,006 151 contracts
A2 · Late Publication €42,712,129,159 4,935 contracts
Contract published to BASE more than 10 days after the signing date
LOW €42,712,129,159 4,935 contracts
A5 · Threshold Splitting €22,743,051 177 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €22,743,051 177 contracts
A6 · Low Competition €91,915,793 97 contracts
Only one bidder participated in a competitive procedure
MEDIUM €91,915,793 97 contracts
A9 · Price Overrun €50,998 5 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €12,223 3 contracts
MEDIUM €38,775 2 contracts
A9 · Abnormal Price Reduction €49,772,190,889 1,586 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €49,772,190,889 1,586 contracts
B5 · Benford's Law Deviation €1,119,077,276 4 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM €1,119,077,276 4 contracts
C3 · Missing Mandatory Fields €45,926,897 112 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €45,926,897 112 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

693
€6,293,597,958
51
€4,427,745,954
117
€2,755,649,371
512
€1,547,449,221
127
€1,465,498,131
70
€1,451,746,778
91
€1,404,595,235
225
€1,393,538,222
160
€1,387,505,100
264
€1,384,325,190
77
€1,371,811,757
42
€1,345,899,313
474
€1,321,027,153
359
€1,248,942,630
31
€1,247,538,126
44
€1,222,389,256
47
€1,218,900,423
46
€1,207,957,071
101
€1,152,390,544
216
€1,113,648,059
Page 1 of 4 · 70 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 1 of 1 · 5 contracts

Medicamentos
PT · fd0165ccb37124d9eaa2 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Price Overrun
€5,772 2025-06-12
Medicamentos
PT · 057a6bde3a83d6f17316 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Price Overrun
€5,723 2025-06-12
040100342025-MEDICAMENTOS PARA A MÁQUINA DE REEMBALAGEM - PROUD
PT · 11225603 · Ajuste Direto Regime G...
A9 · Price Overrun A2 · Late Publication
€728 2025-01-07
AD 08-23 Aquisição do Medicamento Ustecinumab [90 Mg; Sol Inj; Seringa]
PT · 9780819 · Ao abrigo de acordo-qu...
A9 · Price Overrun A2 · Late Publication
€24,096 2023-01-25
AD 76-22 Aquisição do Medicamento APALUTAMIDA [60 MG; CÁP/COMP]
PT · 9576983 · Ao abrigo de acordo-qu...
A9 · Price Overrun A2 · Late Publication
€14,679 2022-11-10
Overview
Total Value Won
€50,579,567,987
Contracts Won
7,070
Score 231630 · CRITICAL RISK
NIF
500189412
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

No director data imported yet.

Director and fiscal identity data for Portuguese companies can be found in the Registo Comercial (publicacoes.mj.pt).

Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned